Cargando…
Aging and neuroplasticity
Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, de...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622467/ https://www.ncbi.nlm.nih.gov/pubmed/23576885 |
_version_ | 1782265838689058816 |
---|---|
author | Smith, Gwenn S. |
author_facet | Smith, Gwenn S. |
author_sort | Smith, Gwenn S. |
collection | PubMed |
description | Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, dementia, and stroke and a range of interventions, including manipulations in behavior (physical and cognitive activity/exercise), physiological factors (caloric restriction, cholesterol), pharmacologic treatments (AMPA receptors) and manipulation of brain magnetic fields and electrical activity (transcranial magnetic stimulation, magnetic seizure therapy, and deep brain stimulation).This editorial will address different facets of neuroplasticity, the need for translational research to interpret neuroimaging data thought to reflect neuroplasticity in the human brain, and the next steps for testing interventions in aging and in disease. |
format | Online Article Text |
id | pubmed-3622467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-36224672013-04-10 Aging and neuroplasticity Smith, Gwenn S. Dialogues Clin Neurosci Guest Editorial Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, dementia, and stroke and a range of interventions, including manipulations in behavior (physical and cognitive activity/exercise), physiological factors (caloric restriction, cholesterol), pharmacologic treatments (AMPA receptors) and manipulation of brain magnetic fields and electrical activity (transcranial magnetic stimulation, magnetic seizure therapy, and deep brain stimulation).This editorial will address different facets of neuroplasticity, the need for translational research to interpret neuroimaging data thought to reflect neuroplasticity in the human brain, and the next steps for testing interventions in aging and in disease. Les Laboratoires Servier 2013-03 /pmc/articles/PMC3622467/ /pubmed/23576885 Text en Copyright: © 2013 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Guest Editorial Smith, Gwenn S. Aging and neuroplasticity |
title | Aging and neuroplasticity |
title_full | Aging and neuroplasticity |
title_fullStr | Aging and neuroplasticity |
title_full_unstemmed | Aging and neuroplasticity |
title_short | Aging and neuroplasticity |
title_sort | aging and neuroplasticity |
topic | Guest Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622467/ https://www.ncbi.nlm.nih.gov/pubmed/23576885 |
work_keys_str_mv | AT smithgwenns agingandneuroplasticity |